For the year ending 2025-12-31, NOV made $8,744M in revenue. $145M in net income. Net profit margin of 1.66%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | 8,744 | 8,870 | 8,583 | 7,237 |
| Product | 4,852 | 4,759 | 4,798 | 4,146 |
| Service | 1,528 | 1,543 | 1,367 | 1,186 |
| Rental | 597 | 558 | 585 | 571 |
| Cost of revenue | 6,977 | 6,860 | 6,750 | 5,903 |
| Gross profit | 1,767 | 2,010 | 1,833 | 1,334 |
| Selling, general and administrative | 1,203 | 1,134 | 1,182 | 1,070 |
| Goodwill and long-lived asset impairment | 70 | - | - | - |
| Operating profit | 494 | 876 | 651 | 264 |
| Interest and financial costs | 88 | 91 | 88 | 78 |
| Interest income | 51 | 38 | 28 | 19 |
| Equity income (loss) in unconsolidated affiliates | -16 | 36 | 119 | 68 |
| Other expense, net | -66 | -28 | -98 | -35 |
| Income before income taxes | 375 | 831 | 612 | 238 |
| U.s federal statutory income tax rate | 79 | - | - | - |
| Foreign income tax rate differential and foreign tax effects-AT | 20 | - | - | - |
| Foreign income tax rate differential and foreign tax effects-BR | 8 | - | - | - |
| Other-BR | 6 | - | - | - |
| Change in deferred tax valuation allowance | 4 | - | - | - |
| Other | 1 | - | - | - |
| Foreign income tax rate differential and foreign tax effects-CA | 5 | - | - | - |
| Other-NL | 3 | - | - | - |
| Withholding taxes-NO | -5 | - | - | - |
| Withholding taxes-SA | 7 | - | - | - |
| Other-SA | 5 | - | - | - |
| Other-GB | -2 | - | - | - |
| Foreign currency gain (loss)-NO | 5 | - | - | - |
| Change in deferred tax valuation allowance-NL | 8 | - | - | - |
| Foreign income tax rate differential and foreign tax effects-Foreign Tax Jurisdiction Other | 26 | - | - | - |
| Foreign income inclusions, net of foreign tax credits | -42 | - | - | - |
| Impact of beat provisions | 14 | - | - | - |
| Nondeductible expenses-NL | 6 | - | - | - |
| Fdii deduction | 7 | - | - | - |
| Income tax credits | 3 | - | - | - |
| Withholding taxes-BR | 7 | - | - | - |
| Change in deferred tax valuation allowance | 82 | - | - | - |
| Impairment of nondeductible goodwill | 8 | - | - | - |
| Tax expense on stock compensation | 14 | - | - | - |
| Nondeductible expenses other | 4 | - | - | - |
| Other | -8 | - | - | - |
| Provision (benefit) for income taxes | 224 | 196 | -373 | 83 |
| Net income | 151 | 635 | 985 | 155 |
| Net income (loss) attributable to noncontrolling interests | 6 | 0 | -8 | - |
| Net income attributable to company | 145 | 635 | 993 | 155 |
| Diluted | 375,000,000 | 396,000,000 | 397,000,000 | 394,000,000 |
| Earnings per share, basic, total | 0.39 | 1.62 | 2.53 | 0.4 |
| Earnings per share, diluted, total | 0.39 | 1.6 | 2.5 | 0.39 |
| Weighted average number of shares outstanding, basic, total | 372,000,000 | 392,000,000 | 393,000,000 | 390,000,000 |
NOV Inc. (NOV)
NOV Inc. (NOV)